The DOI matches its Crossref record; 258 of the 261 references it cites were found in a registry or an index.
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Open accessAbstract
Despite its position as the first-line drug for treatment of type 2 diabetes mellitus, the mechanisms underlying the plasma glucose level-lowering effects of metformin (1,1-dimethylbiguanide) still remain incompletely understood. Metformin is thought to exert its primary antidiabetic action through the suppression of hepatic glucose production. In addition, the discovery that metformin inhibits the mitochondrial respiratory chain complex 1 has placed energy metabolism and activation of AMP-activated protein kinase (AMPK) at the centre of its proposed mechanism of action. However, the role of AMPK has been challenged and might only account for indirect changes in hepatic insulin sensitivity. Various mechanisms involving alterations in cellular energy charge, AMP-mediated inhibition of adenylate cyclase or fructose-1,6-bisphosphatase 1 and modulation of the cellular redox state through direct inhibition of mitochondrial glycerol-3-phosphate dehydrogenase have been proposed for the acute inhibition of gluconeogenesis by metformin. Emerging evidence suggests that metformin could improve obesity-induced meta-inflammation via direct and indirect effects on tissue-resident immune cells in metabolic organs (that is, adipose tissue, the gastrointestinal tract and the liver). Furthermore, the gastrointestinal tract also has a major role in metformin action through modulation of glucose-lowering hormone glucagon-like peptide 1 and the intestinal bile acid pool and alterations in gut microbiota composition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A considerable number of studies have also found that metformin decreases fasting plasma glucose (PG) concentration and hemoglobin A1c by conserving the β-cell function or by decreasing liver glucose production (hepatic gluconeogenesis) (181–184).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [183]
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Cited by
Sorted by citations
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S., & Choi, C. S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,248
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 799
Metformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 791
Self-citationLow-dose metformin targets the lysosomal AMPK pathway through PEN2
Ma, T., Tian, X., Zhang, B., Li, M., Wang, Y., Yang, C., Wu, J., Wei, X., Qu, Q., Yu, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04431-8 · Cited by 644
GDF15 mediates the effects of metformin on body weight and energy balance
Coll, A. P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J. A., Cimino, I., Yang, M., Welsh, P., Virtue, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1911-y · Cited by 584
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Wang, D., Day, E. A., Townsend, L. K., Djordjevic, D., Jørgensen, S. B., & Steinberg, G. R. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00529-7 · Cited by 543
The molecular mechanisms of copper metabolism and its roles in human diseases
Chen, J., Jiang, Y., Shi, H., Peng, Y., Fan, X., & Li, C. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02412-2 · Cited by 498
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Hou, J., Karin, M., & Sun, B. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00459-9 · Cited by 387
Drug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q. C., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 309
Treatments for NAFLD: State of Art
Mantovani, A., & Dalbeni, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052350 · Cited by 244
Chen, J., Liu, B., Yao, X., Yang, X., Sun, J., Yi, J., Xue, F., Zhang, J., Shen, Y., Chen, B., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70657 · Cited by 240
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
The metabolic impact of small intestinal nutrient sensing
Duca, F. A., Waise, T. M. Z., Peppler, W. T., & Lam, T. K. T. (2021) · Nature Communications · doi:10.1038/s41467-021-21235-y · Cited by 216
Current Biomedical Use of Copper Chelation Therapy
Baldari, S., Rocco, G. D., & Toietta, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031069 · Cited by 205
Immunometabolism in the development of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2020) · Immunological Reviews · doi:10.1111/imr.12838 · Cited by 193
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Xu, Y., Xue, D., Bankhead, A., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01013 · Cited by 173
Wu, Z., Zhang, B., Chen, F., Xia, R., Zhu, D., Chen, B., Lin, A., Zheng, C., Hou, D., Li, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1089991 · Cited by 167
AMPK and NRF2: Interactive players in the same team for cellular homeostasis?
Petsouki, E., Cabrera, S. N. S., & Heiß, E. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.014 · Cited by 162
Glycerol-3-phosphate biosynthesis regenerates cytosolic NAD+ to alleviate mitochondrial disease
Liu, S., Fu, S., Wang, G., Cao, Y., Li, L., Li, X., Yang, J. J., Li, N., Shan, Y., Cao, Y., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.013 · Cited by 159
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
Yang, L., Yang, P., Lip, G. Y. H., & Ren, J. T. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.004 · Cited by 159
Metformin, Macrophage Dysfunction and Atherosclerosis
Feng, X., Chen, W., Ni, X., Little, P. J., Xu, S., Tang, L., & Weng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682853 · Cited by 156
Giuliani, G., Rosina, M., & Reggio, A. (2021) · FEBS Journal · doi:10.1111/febs.16080 · Cited by 144
Metformin as an anti-inflammatory agent: a short review
Kristófi, R., & Eriksson, J. W. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0194 · Cited by 143
Liu, Y., Zhou, Z., Hou, J.-T., Xiong, W., Kim, H., Chen, J., Zheng, C., Jiang, X., Yoon, J., & Shen, J. (2022) · Advanced Materials · doi:10.1002/adma.202206121 · Cited by 129
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel
Zhao, M., Lü, J., Li, S., Wang, H., Cao, X., Li, Q., Shi, T., Matsunaga, K., Chen, C., Huang, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25952-2 · Cited by 124
Guasch‐Ferré, M., Santos, J. L., Martínez‐González, M. Á., Clish, C. B., Razquín, C., Wang, D., Liang, L., Li, J., Dennis, C., Corella, D., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa016 · Cited by 118
Marañón, A., Díaz-Pozo, P., Canet, F., Díaz‐Morales, N., Abad‐Jiménez, Z., López‐Domènech, S., Vezza, T., Apostolova, N., Morillas, C., Rocha, M., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102342 · Cited by 117
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 114
Goel, S. K., Singh, R. P., Singh, V., Singh, H., Kumari, P., Chopra, H., Sharma, R., Nepovimová, E., Vališ, M., Kuča, K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1022739 · Cited by 113
Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer
Huang, X., Sun, T., Wang, J., Hong, X., Chen, H., Yan, T., Zhou, C., Sun, D., Yang, C. G., Yu, T., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3042 · Cited by 113
Campbell, C., Wang, T., McNaughton, A. L., Barnes, E. J., & Matthews, P. C. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13452 · Cited by 109
Novel strategies to reverse chemoresistance in colorectal cancer
Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., & Li, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5594 · Cited by 108
Remediation of pharmaceuticals from contaminated water by molecularly imprinted polymers: a review
Zare, E. N., Fallah, Z., Le, V. T., Doan, V., Mudhoo, A., Joo, S., Vasseghian, Y., Tajbakhsh, M., Moradi, O., Sillanpää, M. E. T., et al. (2022) · Environmental Chemistry Letters · doi:10.1007/s10311-022-01439-4 · Cited by 106
Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota
Fei, Y., Chen, Z., Han, S., Zhang, S., Zhang, T., Lu, Y., Berglund, B., Xiao, H., Li, L., & Yao, M. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1958744 · Cited by 105
Li, T., Providencia, R. A., Mu, N., Yin, Y., Chen, M., Wang, Y., Liu, M., Yu, L., Gu, C., & Ma, H. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01202-5 · Cited by 105
Yang, M. H., Darwish, T., Larraufie, P., Rimmington, D., Cimino, I., Goldspink, D. A., Jenkins, B., Koulman, A., Brighton, C. A., Ma, M. K. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81349-7 · Cited by 103
Effects of Nigella sativa seed polysaccharides on type 2 diabetic mice and gut microbiota
Dong, J., Liang, Q., Niu, Y., Jiang, S., Zhou, L., Wang, J., Ma, C., & Kang, W. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.042 · Cited by 101
Lalau, J., Al‐Salameh, A., Hadjadj, S., Goronflot, T., Wiernsperger, N. F., Pichelin, M., Allix, I., Amadou, C., Bourron, O., Duriez, T., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.101216 · Cited by 98
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Ma, M., Zhang, Y., Pu, K., & Tang, W. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00679h · Cited by 100
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97
Yan, C., Tian, X., Li, J., Liu, D., Ye, D., Xie, Z., Han, Y., & Zou, M. (2020) · Diabetes · doi:10.2337/db20-0146 · Cited by 96
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
Zhang, X., Zhao, Y., Chen, S., & Shao, H. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12838 · Cited by 96
New strategies to improve clinical outcomes for diabetic kidney disease
Forst, T. M., Mathieu, C., Giorgino, F., Wheeler, D. C., Παπάνας, Ν., Schmieder, R. E., Halabi, A., Schnell, O., Streckbein, M., & Tuttle, K. R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02539-2 · Cited by 96
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 98
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 93
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
Zheng, Z., Yang, X. H., Zhang, Y., Zu, W., Wen, M., Liu, T., Zhou, C., & Li, L. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120493 · Cited by 91
Zhang, L., Zhang, Y., Shen, S., Wang, X., Dong, L., Li, Q., Ren, W., Li, Y., Bai, J., Gong, Q., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00132-8 · Cited by 92
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 89
DrugMAP: molecular atlas and pharma-information of all drugs
Li, F., Yin, J., Lu, M., Mou, M., Li, Z., Zeng, Z., Tan, Y. C., Wang, S., Chu, X., Dai, H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac813 · Cited by 89
Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
Xiong, W., Sun, K., Zhu, Y., Zhang, X., Zhou, Y., & Zou, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04235-0 · Cited by 88
Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway
Vizuete, A. F. K., Fróes, F. T., Seady, M., Zanotto, C., Bobermin, L. D., Roginski, A. C., Wajner, M., Quincozes‐Santos, A., & Gonçalves, C. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02612-w · Cited by 88
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Metformin: A Potential Candidate for Targeting Aging Mechanisms
Hu, D., Xie, F., Xiao, Y., Chen, L., Zhong, J., Huang, D., Chen, J., Wei, J., Jiang, Y., & Zhong, T. (2021) · Aging and Disease · doi:10.14336/ad.2020.0702 · Cited by 84
Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms
Wu, M., Xu, H., Liu, J., Tan, X., Wan, S., Guo, M., Long, Y., & Xu, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6673525 · Cited by 76
Targeting immune cell metabolism in kidney diseases
Basso, P. J., Andrade‐Oliveira, V., & Câmara, N. O. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00413-7 · Cited by 76
Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
Choksey, A., & Timm, K. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010441 · Cited by 76
Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
Nasykhova, Y. A., Tonyan, Z. N., Mikhailova, A. A., Danilova, M. M., & Glotov, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186842 · Cited by 74
Understanding the action mechanisms of metformin in the gastrointestinal tract
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 78
Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison
Masi, T., & Patel, B. M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00179-y · Cited by 73
Planas, D., Pagliuzza, A., Ponte, R., Fert, A., Marchand, L. R., Massanella, M., Gosselin, A., Mehraj, V., Dupuy, F. P., Isnard, S., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103270 · Cited by 73
Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Valle, A., Pons, D. G., Sastre‐Serra, J., Roca, P., & Nadal‐Serrano, M. (2024) · Biology · doi:10.3390/biology13050302 · Cited by 74
Islam, F., Mitra, S., Nafady, M. H., Rahman, M. T., Tirth, V., Akter, A., Emran, T. B., Mohamed, A. A.-R., Algahtani, A., & El-Kholy, S. S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6144733 · Cited by 70
He, L., Su, Z., & Wang, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1393575 · Cited by 70
Du, F., Liu, M., Wang, J., Hu, L., Zeng, D., Zhou, S., Zhang, L., Wang, M., Xu, X., Li, C., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155398 · Cited by 68
AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals
Chung, M., Choi, H., & Hwang, J. (2021) · Nutrients · doi:10.3390/nu13114050 · Cited by 66
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
Chen, C., Lin, C., & Kung, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413435 · Cited by 64
Xiong, H., Zhai, Y., Meng, Y., Wu, Z., Qiu, A., Cai, Y., Wang, G., & Yang, L. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216732 · Cited by 63
Metformin: Past, Present, and Future
Chaudhary, S., & Kulkarni, A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01539-1 · Cited by 64
Zheng, Y., Ding, Q., Wei, Y., Gou, X., Tian, J., Li, M., & Tong, X. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153455 · Cited by 63
Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes
Li, D., Ruan, G., Zhang, Y., Zhao, Y., Zhu, Z., Ou, Q., Huang, H., Chen, J., Han, W., Tang, S., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac467 · Cited by 62
Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
Hozumi, K., Sugawara, K., Ishihara, T., Ishihara, N., & Ogawa, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-27689-y · Cited by 62
Immunometabolism and metainflammation in obesity
Romantsova, T. I., & Sych, Y. P. (2019) · Obesity and metabolism · doi:10.14341/omet12218 · Cited by 63
Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus
Shafqat, A., Rab, S. A., Ammar, O., Alsalameh, S., Alkhudairi, A., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995993 · Cited by 62
Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches
Althoff, M. D., Gaietto, K. M., Holguín, F., & Forno, E. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202406-1166so · Cited by 59
Metformin effect on gut microbiota: insights for HIV-related inflammation
Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Marette, A., Routy, B., Chen, Y., & Routy, J. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00267-2 · Cited by 59
Li, Z., Tian, J., Cheng, Z., Teng, W., Zhang, W., Bao, Y., Wang, Y., Song, B., Chen, Y., & Li, B. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2055526 · Cited by 58
Antidiabetic Medication and Asthma Attacks
Lee, B., Man, K. K. C., Wong, E., Tan, T., Sheikh, A., & Bloom, C. I. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.5982 · Cited by 57
Zhang, Y., Wang, H., & Xiao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095016 · Cited by 57
Repurposing Antidiabetic Drugs for Cardiovascular Disease
Schubert, M., Hansen, S., Leefmann, J., & Guan, K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.568632 · Cited by 57
Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease
Kim, J., Choe, J., & Park, S. (2021) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.363 · Cited by 56
Diabetes pathogenesis and management: the endothelium comes of age
Love, K. M., Barrett, E. J., Malin, S. K., Reusch, J. E. B., Regensteiner, J. G., & Liu, Z. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab024 · Cited by 55
Anti-diabetics and antimicrobials: Harmony of mutual interplay
Hegazy, W. A. H., Rajab, A. A. H., Lila, A. S. A., & Abbas, H. A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1832 · Cited by 54
The effects of metformin in the treatment of osteoarthritis: Current perspectives
Song, Y., Wu, Z., & Zhao, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952560 · Cited by 55
The effect of metformin on senescence of T lymphocytes
Yang, J. H., Liu, H.-C., Zhang, J., Zou, J., Zhang, X., Chen, W., Gu, Y., & Hong, H. Y. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00394-0 · Cited by 54
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
Giaccari, A., Solini, A., Frontoni, S., & Prato, S. D. (2021) · Diabetes Care · doi:10.2337/dc20-1964 · Cited by 54
Porper, K., Shpatz, Y., Плоткин, Л. Л., Pechthold, R. G., Talianski, A., Champ, C. E., Furman, O., Shimoni-Sebag, A., Symon, Z., Amit, U., et al. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03786-8 · Cited by 54
Glucose Metabolism in Osteoblasts in Healthy and Pathophysiological Conditions
Donat, A., Knapstein, P.-R., Jiang, S., Baranowsky, A., Ballhause, T.-M., Frosch, K.-H., & Keller, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084120 · Cited by 53
Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway
Yang, Z., Wang, M., Zhang, Y., Cai, F., Jiang, B., Zha, W., & Yu, W. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00425 · Cited by 53
Arroyave, F., Montaño, D., & Lizcano, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228685 · Cited by 52
Baker, M. C., Sheth, K., Liu, Y., Lu, D., Lü, R., & Robinson, W. H. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.3646 · Cited by 52
Regulation and inhibition of the DNA sensor cGAS
Hertzog, J., & Rehwinkel, J. (2020) · EMBO Reports · doi:10.15252/embr.202051345 · Cited by 52
Shen, Z., Zhou, H., Li, A., Wu, T., Ji, X., Guo, L., Zhu, X., Zhang, D., & He, X. (2021) · Aging · doi:10.18632/aging.203464 · Cited by 52
Yang, X., Dong, B., An, L., Zhang, Q., Chen, Y., Wang, H., & Song, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.756491 · Cited by 52
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 51
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 52
Xiao, Q., Zhong, Y., Kang, Z.-P., Huang, J., Fang, W., Wei, S., Long, J., Li, S., Zhao, H., & Liu, D. (2022) · Phytotherapy Research · doi:10.1002/ptr.7404 · Cited by 51
Fan, X., Jiao, G., Pang, T., Wen, T., He, Z., Han, J., Zhang, F., & Chen, W. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154740 · Cited by 50
Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
Zhou, Y.-D., Liang, F.-X., Tian, H.-R., Luo, D., Wang, Y., & Yang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1121695 · Cited by 50
Metadata
- Authors
- Foretz, M., Guigas, B., & Viollet, B.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Leiden University Medical Center (NL)
- Venue
- Nature Reviews Endocrinology
- Published
- 2019-08-22
- Volume
- 15
- Issue
- 10
- Pages
- 569-589
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2969928163
- Cited by
- 686
- References
- 261
- Citations by year
- 2026: 80 · 2025: 104 · 2024: 92 · 2023: 122 · 2022: 113 · 2021: 102 · 2020: 68 · 2019: 5
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
- inserm.hal.science
- Licence
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, glucoregulation, hepatic glucose production, gluconeogenesis, AMPK, mitochondrial complex I inhibition, hepatic insulin sensitivity, adenylate cyclase inhibition, FBP1, glycerol-3-phosphate dehydrogenase, redox state, meta-inflammation, obesity, gut microbiota, glucagon-like peptide-1, bile acids
- MeSH terms
- Gastrointestinal Microbiome, Animals, Diabetes Mellitus, Type 2, Electron Transport, Glucose, Humans, Hypoglycemic Agents, Metformin, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review